KTOVPurple Biotech Ltd


$ 0.36 $ 0.00 (-0.86 %)    

Friday, 13-Sep-2024 12:51:39 EDT
QQQ $ 475.13 $ 1.70 (0.36 %)
DIA $ 415.05 $ 2.42 (0.59 %)
SPY $ 561.93 $ 1.66 (0.3 %)
TLT $ 100.47 $ -0.01 (-0 %)
GLD $ 238.70 $ 1.11 (0.47 %)
$ 0.36
$ 0.36
-- x --
-- x --
$ 0.36 - $ 0.36
$ 0.30 - $ 1.80
297,327
na
na
$ 1.11
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kitov-announces-name-change-to-purple-biotech-ltd

TEL AVIV, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (the "Company") (NASDAQ/TASE: KTOV), a clinical...

 kitov-pharma-receives-notice-of-allowance-for-us-patent-covering-its-anti-cancer-drug-candidate-nt219

Patent covers NT219’s combinations with multiple 2nd and 3rd generation EGFR inhibitors, including osimertinib (TAGRISSO®) TEL...

 38-stocks-moving-in-fridays-pre-market-session

Gainers Socket Mobile, Inc. (NASDAQ: SCKT) rose 65.8% to $2.42 in pre-market trading after the company reported a rise in e...

 kitov-pharma-6-k-from-thursday-afternoon-shows-notice-of-annual-shareholder-meeting-proxy-materials-for-event

https://www.sec.gov/Archives/edgar/data/1614744/000121390020032810/ea128688-6k_kitovpharma.htm

 kitov-pharma-highlights-presentation-at-epigenetics-and-metabolism-aacr-special-virtual-conference

Data Further Support Potential of NT219 to Overcome Cancer Drug Resistance TEL AVIV, Israel, Oct. 16, 2020 (GLOBE NEWSWIRE) --...

 33-stocks-moving-in-tuesdays-pre-market-session

Gainers

 hc-wainwright--co-maintains-buy-on-kitov-pharma-adjusts-price-target-to-25

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Kitov Pharma (NASDAQ:KTOV) with a Buy and adjusts the price target...

 kitov-announces-dosing-of-first-patient-in-phase-12-clinical-trial-of-nt219-in-advanced-cancer-patients

TEL AVIV, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. ("Kitov") (NASDAQ/TASE: KTOV), a clinical-stage ...

 kitov-pharma-on-sept-4-received-notification-letter-from-nasdaq-stating-co-has-regained-compliance

On September 4, 2020, Kitov Pharma Ltd. (the “Company”) received a notification letter from Nasdaq stating that Nasdaq has dete...

Core News & Articles

This morning 70 companies reached new 52-week highs.

 46-stocks-moving-in-mondays-pre-market-session

Gainers Stein Mart, Inc. (NASDAQ: SMRT) shares rose 93.8% to $0.2120 in pre-market trading after dropping 11% on Friday. St...

 80-biggest-movers-from-yesterday
80 Biggest Movers From Yesterday
08/14/2020 09:10:50

Gainers NTN Buzztime, Inc. (NYSE: NTN) shares climbed 129.7% to close at $4.25 on Thursday after the company reported a mer...

Core News & Articles

Gainers NTN Buzztime, Inc. (NYSE: NTN) shares jumped 178.6% to $5.16 after the company reported a merger deal with Brooklyn...

 42-stocks-moving-in-thursdays-pre-market-session

Gainers NTN Buzztime, Inc. (NYSE: NTN) shares rose 161.8% to $5.00 in pre-market trading after the company reported a merge...

 kitov-pharma-1h-eps-046
Kitov Pharma 1H EPS $(0.46)
08/11/2020 11:25:36

 hc-wainwright--co-reiterates-buy-on-kitov-pharma-lowers-price-target-to-3

HC Wainwright & Co. reiterates Kitov Pharma (NASDAQ:KTOV) with a Buy and lowers the price target from $12 to $3.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION